Vitamin Shoppe, Inc (NYSE:VSI) is set to release its earnings data before the market opens on Tuesday, August 1st. Analysts expect Vitamin Shoppe to post earnings of $0.40 per share for the quarter. Vitamin Shoppe has set its FY17 guidance at $1.50-1.75 EPS.

Vitamin Shoppe (NYSE:VSI) last posted its earnings results on Wednesday, May 10th. The specialty retailer reported $0.37 EPS for the quarter, missing the Zacks’ consensus estimate of $0.58 by $0.21. Vitamin Shoppe had a net margin of 1.43% and a return on equity of 9.35%. The company had revenue of $316.90 million during the quarter, compared to analyst estimates of $325.71 million. During the same period in the previous year, the company earned $0.67 EPS. The company’s quarterly revenue was down 5.9% compared to the same quarter last year. On average, analysts expect Vitamin Shoppe to post $1.57 EPS for the current fiscal year and $1.68 EPS for the next fiscal year.

Vitamin Shoppe, Inc (NYSE VSI) opened at 10.55 on Tuesday. The firm has a market cap of $244.37 million, a PE ratio of 13.58 and a beta of 0.69. The firm has a 50-day moving average of $11.16 and a 200-day moving average of $17.12. Vitamin Shoppe, Inc has a 52-week low of $9.80 and a 52-week high of $32.31.

TRADEMARK VIOLATION WARNING: “Vitamin Shoppe, Inc (VSI) Scheduled to Post Earnings on Tuesday” was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this report on another site, it was illegally stolen and republished in violation of United States & international trademark & copyright law. The legal version of this report can be read at

A number of analysts have issued reports on the company. Zacks Investment Research raised Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 18th. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Barclays PLC reissued an “equal weight” rating and issued a $13.00 price target (down from $24.00) on shares of Vitamin Shoppe in a research note on Sunday, May 14th. Gabelli lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research note on Thursday, May 11th. Finally, Morgan Stanley raised Vitamin Shoppe from an “underweight” rating to an “equal weight” rating and set a $14.00 price target on the stock in a research note on Thursday, May 11th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and one has assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $24.00.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Earnings History for Vitamin Shoppe (NYSE:VSI)

Receive News & Ratings for Vitamin Shoppe Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc and related companies with's FREE daily email newsletter.